genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Venom Goes to Bat as Novel Medical Treatment
News
BMS Buyout Not Stopping Celgene from Launching Cancer Collaborations with Kyn,…
News
Obesity-Regulating Brain Signaling Pathway Genes Identified
News
Cancer Fighting T Cells Produced Continuously through New Method
News
Stem Cell Therapy Patch for Macular Degeneration Sees the Light of…
Insights
Insights
Literature Review: Advanced Biologic Therapies and Advanced Biologics Manufacturing
Insights
Top 10 Global Biopharma IPOs of 2018
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
A-Lists
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Insights
Top 10 Molecular Millionaires of 2018
A-Lists
Top 10 Pharma Companies of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Venom Goes to Bat as Novel Medical Treatment
News
BMS Buyout Not Stopping Celgene from Launching Cancer Collaborations with Kyn,…
News
Obesity-Regulating Brain Signaling Pathway Genes Identified
News
Cancer Fighting T Cells Produced Continuously through New Method
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Events
AACR Annual Meeting
Events
Circulating Biomarkers World Congress
Events
Bio Europe Spring
Events
Phar-East
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Pharmacokinetics
Pharmacokinetics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pharmacokinetics
Month-Long Diabetes Control Possible with New Injection
Pharmacokinetics
Novozymes, Almac Ally to Offer Drug Targeting, Pharmacokinetics Service
Pharmacokinetics
Organs-on-Chips a Step Closer to Reality
Pharmacokinetics
Jump-Starting Phase I Clinical Investigations
Pharmacokinetics
AZ Looks to Charles River Labs for In Vivo Biology
Pharmacokinetics
Creating a Human Body on a Chip
Pharmacokinetics
Sygnature Discovery and Saretius Couple Respective Expertise in Drug Discovery and...
Pharmacokinetics
Quintiles to Buy Advion’s Bioanalytical Services Division
Pharmacokinetics
Eye Movements in Mice Used to Evaluate CNS-Active Drug Efficacy, Receptor...
Pharmacokinetics
Profil Institute to Use Rosa PK/PD Models in Clinical Research Programs
Pharmacokinetics
RainDance Forges Separate Pacts with Ambry and Roche to Advance ADME...
Pharmacokinetics
Roche to Assess Cerep’s BioPrint Database and Pharmaco-Informatics Tools
Pharmacokinetics
EMD Millipore Selects Gyros Platform for Assay Miniaturization
Pharmacokinetics
Roche Gains Access to Cerep’s Pharmacology and ADME Database
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Researchers claim reproducible drug-related changes in OKR responses can be used with preclinical drug development tests. [krishnacreations - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug8_2011_22415259_ColorfulEyeball_SchepensReNeuronCollab2102683128-324x160.jpg "Eye Movements in Mice Used to Evaluate CNS-Active Drug Efficacy, Receptor Interaction, Pharmacokinetics, and Toxicity")
